Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Neuropilin-1 Regulates the Secondary CD8 T Cell Response to Virus Infection.

Hwang JY, Sun Y, Carroll CR, Usherwood EJ.

mSphere. 2019 May 22;4(3). pii: e00221-19. doi: 10.1128/mSphere.00221-19.

2.

Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA.

Habison AC, de Miranda MP, Beauchemin C, Tan M, Cerqueira SA, Correia B, Ponnusamy R, Usherwood EJ, McVey CE, Simas JP, Kaye KM.

PLoS Pathog. 2017 Sep 14;13(9):e1006555. doi: 10.1371/journal.ppat.1006555. eCollection 2017 Sep.

3.

MicroRNA miR-155 Is Necessary for Efficient Gammaherpesvirus Reactivation from Latency, but Not for Establishment of Latency.

Crepeau RL, Zhang P, Usherwood EJ.

J Virol. 2016 Aug 12;90(17):7811-21. doi: 10.1128/JVI.00521-16. Print 2016 Sep 1.

4.

Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Hu Z, Blackman MA, Kaye KM, Usherwood EJ.

J Immunol. 2015 Mar 15;194(6):2746-56. doi: 10.4049/jimmunol.1401928. Epub 2015 Feb 6.

5.

CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.

Hu Z, Molloy MJ, Usherwood EJ.

Cell Mol Immunol. 2016 Jan;13(1):82-93. doi: 10.1038/cmi.2014.128. Epub 2014 Dec 29.

6.

MCL1 enhances the survival of CD8+ memory T Cells after viral infection.

Gui J, Hu Z, Tsai CY, Ma T, Song Y, Morales A, Huang LH, Dmitrovsky E, Craig RW, Usherwood EJ.

J Virol. 2015 Feb;89(4):2405-14. doi: 10.1128/JVI.02480-14. Epub 2014 Dec 10.

7.

Immune escape of γ-herpesviruses from adaptive immunity.

Hu Z, Usherwood EJ.

Rev Med Virol. 2014 Nov;24(6):365-78. doi: 10.1002/rmv.1791. Epub 2014 Apr 15. Review.

8.

CX3CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer.

Hart KM, Usherwood EJ, Berwin BL.

Immunol Cell Biol. 2014 Jul;92(6):499-508. doi: 10.1038/icb.2014.13. Epub 2014 Mar 11.

9.
10.

CD4 and CD8 T cells directly recognize murine gammaherpesvirus 68-immortalized cells and prevent tumor outgrowth.

Liang X, Crepeau RL, Zhang W, Speck SH, Usherwood EJ.

J Virol. 2013 May;87(10):6051-4. doi: 10.1128/JVI.00375-13. Epub 2013 Mar 20.

11.

Critical role for all-trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation.

Allie SR, Zhang W, Tsai CY, Noelle RJ, Usherwood EJ.

J Immunol. 2013 Mar 1;190(5):2178-87. doi: 10.4049/jimmunol.1201945. Epub 2013 Jan 21.

12.

MicroRNA miR-155 affects antiviral effector and effector Memory CD8 T cell differentiation.

Tsai CY, Allie SR, Zhang W, Usherwood EJ.

J Virol. 2013 Feb;87(4):2348-51. doi: 10.1128/JVI.01742-12. Epub 2012 Dec 5.

13.

Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence.

Habison AC, Beauchemin C, Simas JP, Usherwood EJ, Kaye KM.

J Virol. 2012 Nov;86(21):11863-76. doi: 10.1128/JVI.01656-12. Epub 2012 Aug 22.

14.

Strain-dependent requirement for IFN-γ for respiratory control and immunotherapy in murine gammaherpesvirus infection.

Tsai CY, Hu Z, Zhang W, Usherwood EJ.

Viral Immunol. 2011 Aug;24(4):273-80. doi: 10.1089/vim.2011.0004.

15.

Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.

Byrne KT, Côté AL, Zhang P, Steinberg SM, Guo Y, Allie R, Zhang W, Ernstoff MS, Usherwood EJ, Turk MJ.

J Clin Invest. 2011 May;121(5):1797-809. doi: 10.1172/JCI44849. Epub 2011 Apr 11.

16.

Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus.

Molloy MJ, Zhang W, Usherwood EJ.

J Immunol. 2011 Jun 1;186(11):6218-26. doi: 10.4049/jimmunol.1003812. Epub 2011 Apr 29.

17.

Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection.

Allie SR, Zhang W, Fuse S, Usherwood EJ.

J Immunol. 2011 Jun 1;186(11):6280-6. doi: 10.4049/jimmunol.1003870. Epub 2011 Apr 27.

18.

Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.

Fuse S, Tsai CY, Rommereim LM, Zhang W, Usherwood EJ.

Cell Immunol. 2011;266(2):130-4. doi: 10.1016/j.cellimm.2010.09.008. Epub 2010 Oct 30.

19.

Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery.

Gunturu KS, Meehan KR, Mackenzie TA, Crocenzi TS, McDermott D, Usherwood EJ, Margolin KA, Crosby NA, Atkins MB, Turk MJ, Ahonen C, Fuse S, Clark JI, Fisher JL, Noelle RJ, Ernstoff MS.

J Clin Oncol. 2010 Mar 1;28(7):1196-202. doi: 10.1200/JCO.2009.24.8153. Epub 2010 Feb 1.

20.

CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.

Obar JJ, Molloy MJ, Jellison ER, Stoklasek TA, Zhang W, Usherwood EJ, Lefrançois L.

Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):193-8. doi: 10.1073/pnas.0909945107. Epub 2009 Dec 4.

21.

A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector.

Zhang W, Zhang T, Turk MJ, Usherwood EJ.

Cancer Immunol Immunother. 2010 May;59(5):707-13. doi: 10.1007/s00262-009-0790-8.

22.

Cutting edge: IL-2 immune complexes as a therapy for persistent virus infection.

Molloy MJ, Zhang W, Usherwood EJ.

J Immunol. 2009 Apr 15;182(8):4512-5. doi: 10.4049/jimmunol.0804175.

23.

Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1.

Fuse S, Tsai CY, Molloy MJ, Allie SR, Zhang W, Yagita H, Usherwood EJ.

J Immunol. 2009 Apr 1;182(7):4244-54. doi: 10.4049/jimmunol.0802041.

24.

Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions.

Fuse S, Molloy MJ, Usherwood EJ.

Crit Rev Immunol. 2008;28(2):159-83. Review.

PMID:
18540829
25.

Tumor-specific T-cell memory: clearing the regulatory T-cell hurdle.

Côté AL, Usherwood EJ, Turk MJ.

Cancer Res. 2008 Mar 15;68(6):1614-7. doi: 10.1158/0008-5472.CAN-07-6012. Review.

26.

Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.

Ahonen CL, Wasiuk A, Fuse S, Turk MJ, Ernstoff MS, Suriawinata AA, Gorham JD, Kedl RM, Usherwood EJ, Noelle RJ.

Blood. 2008 Mar 15;111(6):3116-25. doi: 10.1182/blood-2007-09-114371. Epub 2008 Jan 17.

28.

Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor.

Zhang P, Côté AL, de Vries VC, Usherwood EJ, Turk MJ.

Cancer Res. 2007 Jul 1;67(13):6468-76.

29.
30.

CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.

Fuse S, Obar JJ, Bellfy S, Leung EK, Zhang W, Usherwood EJ.

J Virol. 2006 Sep;80(18):9159-70.

31.

Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection.

Obar JJ, Fuse S, Leung EK, Bellfy SC, Usherwood EJ.

J Virol. 2006 Sep;80(17):8303-15.

32.

Control of murine gammaherpesvirus infection is independent of NK cells.

Usherwood EJ, Meadows SK, Crist SG, Bellfy SC, Sentman CL.

Eur J Immunol. 2005 Oct;35(10):2956-61.

33.
34.

IL-15-independent proliferative renewal of memory CD8+ T cells in latent gammaherpesvirus infection.

Obar JJ, Crist SG, Leung EK, Usherwood EJ.

J Immunol. 2004 Aug 15;173(4):2705-14.

35.

Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin.

Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, Marzo AL, Ward RL, Woodland DL, Lefrançois L.

J Immunol. 2004 Apr 15;172(8):4875-82.

36.
37.

Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis.

Macrae AI, Usherwood EJ, Husain SM, Flaño E, Kim IJ, Woodland DL, Nash AA, Blackman MA, Sample JT, Stewart JP.

J Virol. 2003 Sep;77(17):9700-9.

38.
39.

Antigen expression during murine gamma-herpesvirus infection.

Woodland DL, Flaño E, Usherwood EJ, Liu Luzheng, Kim IJ, Husain SM, Sample JT, Blackman MA.

Immunobiology. 2001 Dec;204(5):649-58. Review.

PMID:
11846230
40.

Vaccination against murine gamma-herpesvirus infection.

Woodland DL, Usherwood EJ, Liu L, Flaño E, Kim IJ, Blackman MA.

Viral Immunol. 2001;14(3):217-26. Review.

PMID:
11572633
41.

Latent antigen vaccination in a model gammaherpesvirus infection.

Usherwood EJ, Ward KA, Blackman MA, Stewart JP, Woodland DL.

J Virol. 2001 Sep;75(17):8283-8.

42.

Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs.

Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL.

J Exp Med. 2001 Apr 16;193(8):981-6.

43.
44.

Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.

Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, Woodland DL.

J Immunol. 2001 Feb 1;166(3):1813-22.

45.

Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.

Usherwood EJ, Roy DJ, Ward K, Surman SL, Dutia BM, Blackman MA, Stewart JP, Woodland DL.

J Exp Med. 2000 Oct 2;192(7):943-52.

46.

Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.

Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R.

J Virol. 2000 Apr;74(8):3659-67.

47.
48.

Apoptotic cells are generated at every division of in vitro cultured T cell lines.

Usherwood EJ, Crowther G, Woodland DL.

Cell Immunol. 1999 Sep 15;196(2):131-7.

PMID:
10527565
49.

Functionally heterogeneous CD8(+) T-cell memory is induced by Sendai virus infection of mice.

Usherwood EJ, Hogan RJ, Crowther G, Surman SL, Hogg TL, Altman JD, Woodland DL.

J Virol. 1999 Sep;73(9):7278-86.

50.

Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.

Liu L, Flaño E, Usherwood EJ, Surman S, Blackman MA, Woodland DL.

J Immunol. 1999 Jul 15;163(2):868-74.

Supplemental Content

Loading ...
Support Center